Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials

INTRODUCTION: The Kidney Cancer Research Network of Canada (KCRNC) collaborated to prepare this consensus statement about the use of target agents as adjuvant therapy in patients with non-metastatic renal cell carcinoma (nmRCC) after nephrectomy. We reviewed the published data and performed a meta-a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can Urol Assoc J
Main Authors: Karakiewicz, Pierre I., Zaffuto, Emanuele, Kapoor, Anil, Basappa, Naveen S., Bjarnason, Georg A., Blais, Normand, Breau, Rodney H., Canil, Christina, Drachenberg, Darrel, Hotte, Sebastien J., Jeldres, Claudio, Jewett, Michael A.S., Kassouf, Wassim, Kollmannsberger, Christian, Lavallée, Luke T., Maloni, Ranjena, Patenaude, Francois, Pouliot, Frédéric, Reaume, M. Neil, Sabbagh, Robert, Shayegan, Bobby, So, Alan, Soulières, Denis, Tanguay, Simon, Wood, Lori, Bandini, Marco
Formato: Artigo
Idioma:Inglês
Publicado em: Canadian Medical Association 2018
Assuntos:
Consensus Statement
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5994982/
https://ncbi.nlm.nih.gov/pubmed/29877179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5187
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados